Fucoxanthine

Studies With Fucoxanthine
Evidence suggests that when humans supplement with fucoxanthine, they may induce the expression of UCP1 in their stores of white fat. In the words of one researcher, this makes fucoxanthin an attractive new target for “pharmacological management of complex pathological syndromes such as obesity, type 2 diabetes or chronic inflammatory diseases.”

The first study was aimed at determining the effects of fucoxanthine supplementation. The results were very promising—subjects who took fucoxanthine generated greater absolute increases in energy expenditure. These researchers concluded that supplementation including fucoxanthine can significantly increase metabolism and could well have profound anti-obesity properties.

That conclusion was put to the test by antother study that looked at the addition of fucoxanthine supplementation on body weight, body and liver fat content, and a variety of plasma risk factor markers in a group of obese, non-diabetic women. The 110 subjects in this placebo-controlled study were randomized into two groups who received the following:

• Either supplementation including fucoxanthine or
• 200 mg placebo.Treatment was given in both groups 15-30 minutes before meals three times per day for 16 weeks in conjunction with an 1,800-calorie/day diet.

Promising Results
After six weeks on the supplements, there was a statistically significant reduction in body weight in the supplemented group who had normal liver fat content, and by eight weeks the fatty-liver group was also showing significant weight loss, compared with placebo. By the end of the 16-week study, women with fatty livers had lost an average of more than 15 pounds, compared with just three pounds in their placebo-supplemented peers! The normal liver-fat group had similar results, losing an average of nearly 14 pounds, compared with just over three pounds in the placebo group.29 In other words, both active groups lost just under a pound a week over the entire study period, which is a healthy, sustainable, and realistic rate of weight loss.

Weight loss alone is not the only or even the best marker of improvement in the risks posed by fat. Supplemented patients in this study also demonstrated a significant reduction in visceral fat. Visceral fat is the type of fat that covers the organs of the abdominal cavity like the liver.

No patient in this study reported any side effects.
Unlike products that produce undesirable side effects, fucoxanthine has demonstrated remarkable health benefits that may lower one’s risk of heart disease, diabetes, and even cancer.

Contact Us | FAQ | Privacy Policy | Purchase Agreement